Early detection of gastric cancer in China: progress and opportunities

Affiliations

¹ Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital and Institute, Beijing 100142, China.

Hengmin Xu et al. Cancer Biol Med. 2022.

. 2022 Dec 12;19(12):1622-1628.

doi: 10.20892/j.issn.2095-3941.2022.0655.

¹ Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital and Institute, Beijing 100142, China.

No abstract available

Conflict of interest statement

No potential conflicts of interest are disclosed.

1. Wei WQ, Zeng HM, Zheng RS, Zhang SW, An L, Chen R, et al. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 2020;21:e342–9. - PubMed
1. Li WQ, Qin XX, Li ZX, Wang LH, Liu ZC, Fan XH, et al. Beneficial effects of endoscopic screening on gastric cancer and optimal screening interval: a population-based study. Endoscopy. 2022;54:848–58. - PubMed
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71:209–49. - PubMed
1. Zheng RS, Zhang SW, Zeng HM, Wang SM, Sun KX, Chen R, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Center. 2022;2:1–9. - PMC - PubMed
1. Cao MM, Li H, Sun DQ, He SY, Yan XX, Yang F, et al. Current cancer burden in China: epidemiology, etiology, and prevention. Cancer Biol Med. 2022;19:1121–38. - PMC - PubMed